These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23748820)
1. Pilot research for the correlation between the expression pattern of E-cadherin-β-catenin complex and lymph node metastasis in early gastric cancer. Yoshii T; Miyagi Y; Nakamura Y; Kobayashi O; Kameda Y; Ohkawa S Tumori; 2013; 99(2):234-8. PubMed ID: 23748820 [TBL] [Abstract][Full Text] [Related]
2. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. Xiangming C; Hokita S; Natsugoe S; Tanabe G; Baba M; Takao S; Kuroshima K; Aikou T Oncology; 1999; 57(2):131-7. PubMed ID: 10461060 [TBL] [Abstract][Full Text] [Related]
3. Expression of e-cadherin and catenins in early gastric cancer. Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224 [TBL] [Abstract][Full Text] [Related]
4. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Jawhari A; Jordan S; Poole S; Browne P; Pignatelli M; Farthing MJ Gastroenterology; 1997 Jan; 112(1):46-54. PubMed ID: 8978342 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients. Hou F; Yuan W; Huang J; Qian L; Chen Z; Ge J; Wu S; Chen J; Wang J; Chen Z Med Oncol; 2012 Dec; 29(4):2691-700. PubMed ID: 22189617 [TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911 [TBL] [Abstract][Full Text] [Related]
8. Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance. Ayed-Guerfali DB; Hassairi B; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R Tumour Biol; 2014 Mar; 35(3):1775-83. PubMed ID: 24197976 [TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma. Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314 [TBL] [Abstract][Full Text] [Related]
11. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours. De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Rutteman GR; Gärtner Mde F APMIS; 2007 Apr; 115(4):327-34. PubMed ID: 17504299 [TBL] [Abstract][Full Text] [Related]
12. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. Liu J; Ikeguchi M; Nakamura S; Kaibara N J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532 [TBL] [Abstract][Full Text] [Related]
13. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ Digestion; 2001; 64(2):111-9. PubMed ID: 11684825 [TBL] [Abstract][Full Text] [Related]
14. Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma. Yoon CS; Hyung WJ; Lee JH; Chae YS; Won NH; Yeom BW; Choi JS Hepatogastroenterology; 2008; 55(86-87):1916-20. PubMed ID: 19102422 [TBL] [Abstract][Full Text] [Related]
15. Expression of liver-intestine cadherin and its correlation with lymph node metastasis in gastric cancer: can it predict N stage preoperatively? Park SS; Kang SH; Park JM; Kim JH; Oh SC; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ Ann Surg Oncol; 2007 Jan; 14(1):94-9. PubMed ID: 17063305 [TBL] [Abstract][Full Text] [Related]
16. Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. Cai J; Ikeguchi M; Tsujitani S; Maeta M; Liu J; Kaibara N Gastric Cancer; 2001; 4(2):66-74. PubMed ID: 11706763 [TBL] [Abstract][Full Text] [Related]
17. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis. Czyzewska J; Guzińska-Ustymowicz K; Ustymowicz M; Pryczynicz A; Kemona A Folia Histochem Cytobiol; 2010 Jan; 48(1):37-45. PubMed ID: 20529814 [TBL] [Abstract][Full Text] [Related]
18. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Chetty R; Serra S; Asa SL Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809 [TBL] [Abstract][Full Text] [Related]
19. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
20. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer. He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]